RNA (Atrium Therapeutics) Tax Rate %: 0.00% (As of Mar. 2026)


RNA Atrium Therapeutics Inc RNA
12 GF Score
Price $13.51
! 1 Warning Sign
View Full Analysis

What is Atrium Therapeutics Tax Rate %?

Atrium Therapeutics RNA +1.56% 12 Tax Rate % is 0.00% as of Mar. 2026. GuruFocus rates RNA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Atrium Therapeutics's Tax Expense for the three months ended in Mar. 2026 was $0.00 Mil. Atrium Therapeutics's Pre-Tax Income for the three months ended in Mar. 2026 was $-16.63 Mil. Therefore, Atrium Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 was 0.00%.

Atrium Therapeutics Tax Rate % Related Terms

Atrium Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Atrium Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atrium Therapeutics Tax Rate % Chart

Atrium Therapeutics Annual Data
Trend Dec23 Dec24 Dec25
Tax Rate %
0.00 -90.09 0.18

Atrium Therapeutics Quarterly Data
Dec23 Dec24 Mar25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial -84.28 0.00 0.00 -0.07 0.00
RNA
12GF Score
Atrium Therapeutics Inc RNA
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atrium Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Atrium Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-0.142/-76.826
=0.18 %

Atrium Therapeutics's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=0/-16.633
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.00% mean?
Atrium Therapeutics (RNA) has a Tax Rate % of 0.00% as of Mar. 2026.
Is Atrium Therapeutics' Tax Rate % too high?
Atrium Therapeutics' current Tax Rate % is 0.00%. Overall, Atrium Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Atrium Therapeutics' Tax Rate % compare to CNTN and QTTB?
Atrium Therapeutics' Tax Rate % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Atrium Therapeutics's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atrium Therapeutics stock overvalued right now?
Atrium Therapeutics (RNA) has a current Tax Rate % of 0.00%. The current Tax Rate % is 0.00%. Atrium Therapeutics' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Atrium Therapeutics (RNA), the current Tax Rate % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atrium Therapeutics Business Description

Address 10578 Science Center Drive, Suite 125, San Diego, CA, USA, 92121
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
12GF Score

Get the complete analysis for RNA

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.51
Price